"COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma." Journal of Dermatological Treatment, 33(3), pp. 1782–1783
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
The work was supported by the PROGRES Q28 (oncology) research program awarded by the Charles University, Prague.